Latest Innovation News

Locksley Resources has gained critical regulatory approval and secured contractors to advance its Mojave Project, accelerating exploration of antimony and rare earth elements in California.

Micro-X has landed a $3.3 million order from the Malaysian Ministry of Health for its Rover Plus mobile X-ray units, marking a significant step in its Southeast Asian expansion. Delivery is set to begin in October 2025.

The Calmer Co (ASX – CCO) reported an impressive $8 million revenue for FY25, marking 86% year-over-year growth and positioning itself as a global leader in the emerging kava market. With expanding retail presence and strong US sales, the company is on track to break even in 2026.

Litchfield Minerals has confirmed a continuous mineralised strike of over 3km at its Oonagalabi Formation, revealing new copper, zinc, and silver zones. Upcoming drilling and geophysical surveys aim to test the system’s extensions and depth potential.

Aurora Labs has secured a $450,000 Phase 2 contract from the Australian Department of Defence to prototype a high-thrust, fuel-efficient propulsion system for unmanned aerial systems, building on its innovative 3D metal printing technology.

Bank of Queensland announces a $170 million goodwill impairment in its retail banking unit for FY25, reflecting structural industry changes but maintaining strong cash earnings and capital ratios.

Pacific Smiles Group announces the resignation of CEO Gary Carroll and the appointment of Michelle Dries as his successor, signaling a new chapter for the dental services provider.

Altech has detailed its Sodium Nickel Chloride (SNC) battery technology designed specifically for hazardous explosive environments, highlighting superior safety, longevity, and minimal maintenance compared to traditional battery chemistries.

TPG Telecom launches an innovative handset receivables financing structure expected to free up $600 million in cash flow for FY25 and plans a $3 billion capital reduction with a reinvestment plan for minority shareholders.

WhiteHawk Limited has completed a significant share placement to Lakeba Group, bringing the investor into its top 10 shareholders and signaling a strategic partnership aimed at accelerating growth in cybersecurity and AI.

Arovella Therapeutics has demonstrated that its novel CLDN18.2 CAR-T cells effectively eliminate pancreatic cancer cells in vitro, matching the performance of a leading competitor’s product. The company is now advancing this CAR into its innovative iNKT cell platform to tackle solid tumours.

Chimeric Therapeutics reports encouraging Phase 1B data from its ADVENT-AML trial, showing safety and multiple complete responses in high-risk AML patients treated with CORE-NK combined with standard therapies.